设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2022 年第 12 期 第 17 卷

血流储备分数在急性ST段抬高型心肌梗死合并多支病变患者急诊经皮冠状动脉介入治疗中的应用

Application of fractional flow reserve in primary percutaneous coronary intervention for patients with acute STsegment elevation myocardial infarction complicated with multivessel disease

作者:赵春勇1靳晓宇2金洪珍1赵慧强1黄觊3李南3

英文作者:Zhao Chunyong1 Jin Xiaoyu2 Jin Hongzhen1 Zhao Huiqiang1 Huang Ji3 Li Nan3

单位:1首都医科大学附属北京友谊医院平谷医院心内科,北京101200;2北京市平谷区刘家店社区卫生服务中心,北京101206;3首都医科大学附属北京安贞医院冠心病中心六病区,北京100029

英文单位:1Department of Cardiology Beijing Friendship Hospital Pinggu Campus Capital Medical University Beijing 101200 China; 2Liujiadian Community Health Service Center Pinggu District Beijing 101206 China; 3Sixth Ward Department of Cardiology Beijing Anzhen Hospital Capital Medical University Beijing 100029 China

关键词:急性ST段抬高型心肌梗死;多支病变;血流储备分数;非梗死相关血管

英文关键词:AcuteSTsegmentelevationmyocardialinfarction;Multivesseldisease;Fractionalflowreserve;Noninfarctrelatedvessels

  • 摘要:
  • 目的  探讨血流储备分数(FFR)在急性ST段抬高型心肌梗死(STEMI)合并多支病变患者急诊经皮冠状动脉介入(PCI)治疗中的应用价值。方法  入选2018年2月至2019年8月首都医科大学附属北京友谊医院平谷医院及首都医科大学附属北京安贞医院STEMI合并多支病变并已行梗死相关血管急诊PCI治疗患者101例。按随机数字表法将患者分为2组,一组以FFR为指导,根据FFR处理非梗死相关血管完成完全血运重建(完全血运重建组,48例);另一组以冠状动脉造影为指导,在急性期仅处理梗死相关血管(仅处理梗死相关血管组,53例)。比较2组患者PCI相关指标和术后随访心脑血管事件发生情况。主要终点为随访12个月时全因死亡、非致死性心肌梗死、再次血运重建和脑血管事件。结果  完全血运重建组手术操作时间长于仅处理梗死相关血管组[(65±11)min比(59±8)min],支架总长短于仅处理梗死相关血管组[(31±10)mm比(36±10)mm],差异均有统计学意义(均P<0.05)。完全血运重建组在FFR指导下行非梗死相关血管PCI处理26例(54.2%)。完全血运重建组随访12个月时心绞痛、再次血运重建和主要终点事件发生率均低于仅处理梗死相关血管组[4.2%(2/48)比18.9%(10/53)、6.2%(3/48)比22.6%(12/53)、8.3%(4/48)比24.5%(13/53)],差异均有统计学意义(均P<0.05)。结论  对于STEMI合并多支病变并已行梗死相关血管急诊PCI治疗患者,急性期在FFR指导下对非梗死相关血管进行完全血运重建,比仅进行梗死相关血管PCI降低了心脑血管事件的发生风险。

  • Objective  To explore the application value of fractional flow reserve (FFR) in primary percutaneous coronary intervention (PCI) for patients with acute STsegment elevation myocardial infarction (STEMI) complicated with multivessel disease. Methods  From February 2018 to August 2019, totally 101 STEMI patients with multivessel disease undergoing primary PCI were selected from Pinggu Hospital, Beijing Friendship Hospital, Capital Medical University and Beijing Anzhen Hospital, Capital Medical University. Patients were randomized divided into two groups. The one underwent FFR guided complete revascularization to treatment non infarct related vessels (complete revascularization group, 48 cases), and the other one underwent coronary angiography guided incomplete revascularization to treat infarct related vessels only in the acute phase (only infarct related vessels treated group, 53 cases). PCI related indexes and occurrence of postoperative cardiocerebral vascular events during followup were compared bewteen the two groups. The primary endpoint was allcause death, nonfatal myocardial infarction, revascularization, and cerebrovascular events at 12 months of followup. Results  Compared with the only infarct related vessels treated group, the total operation time in the complete revascularization group was longer[(65±11)min vs (59±8)min], and the total length of the stent was shorter[(31±10)mm vs (36±10)mm] (both P<0.05). In the complete revascularization group, 26 cases (54.2%) were treated with PCI for non infarct related vessels under the guidance of FFR. The incidences of angina pectoris, revascularization and primary endpoint events in the complete revascularization group were lower than those in the only infarct related vessels treated group at 12 months of followup[4.2%(2/48) vs 18.9%(10/53), 6.2%(3/48) vs 22.6%(12/53), 8.3%(4/48) vs 24.5%(13/53)] (all P<0.05). Conclusion  For STEMI patients with multivessel disease undergoing primary PCI, FFR guided complete revascularization reduces the risk of cardiocerebral vascular events than PCI only treated infarct related vessels.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭